Get Brochure

Literature Monitoring Services

Advanced Pharmacovigilance Literature Screening for Drug Safety

In pharmacovigilance, medical literature monitoring is an essential tool for identifying critical safety data. As regulations become stringent, Marketing Authorization Holders (MAHs) face increasing challenges to integrate this data into their pharmacovigilance practices, ensuring full compliance. Consistent pharmacovigilance literature monitoring is key to promptly detecting Individual Case Safety Reports (ICSRs), which not only helps meet regulatory requirements but also guarantees relevant safety information is incorporated into aggregate reports. Automated literature monitoring, driven by artificial intelligence (AI) tools, helps in making medical literature monitoring more efficient, saving on time. This timely approach aids in signal detection and fosters compliance. Neglecting these processes, however, can result in costly errors or gaps in reporting, leading to adverse audit or inspection findings that could harm the MAH’s standing. Regular literature review isn’t just a regulatory necessity; it’s a proactive strategy to protect patient safety and maintain regulatory excellence.

DDReg offers specialized and comprehensive literature monitoring and surveillance services to organizations. The literature monitoring team understands the crucial role that medical and scientific literature plays in providing a source of important information for the benefit-risk assessment of pharmaceutical and allied products. Our team works to ensure that there is no compromise in identifying & processing the literature ICSRs and/or safety signals DDReg literature surveillance team has expertise in devising comprehensive search strategies, carrying out review of weekly outcomes from global (indexed) literature databases such as PubMED or EMBASE,local (non-indexed) literature, and triaging & booking the cases that are identified.The team also performs duplicate checks and quality review on cases, abstracts, and articles.

DDReg’s Literature Monitoring expertise includes:

  • Weekly monitoring of publications in different databases such as Embase, PubMed or Medline
  • Weekly monitoring of non-indexed literature, including journals, on local databases for target countries in local language
  • Weekly monitoring of ICSRs received as through Medical Literature Monitoring (MLM) or Anonymized Single Patient Reports (ASPRs)
  • Devising comprehensive literature search strategy for weekly outcome from PubMED &/or EMBASE
  • Documentation of outcomes using abstract or full text articles that assist in identifying ICSRs ,
  • Maintaining the complete tracking of literature cases based on Validity,
  • Use in Aggregate reports and PSUR/ RMP
  • Use in identifying the signals

Basics of Literature Monitoring in Pharmacovigilance

Literature monitoring is a critical component in pharmacovigilance. It is a systematic process of reviewing medical and scientific literature, journals, and other relevant sources. Frequent monitoring of these sources helps to identify information related to adverse effects, drug safety issues, and any emerging risks that are associated with drugs. Literature monitoring in pharmacovigilance supports traditional pharmacovigilance activities and provides valuable and more holistic safety insights to the drug’s safety profile. Essential components of literature monitoring include searches on global literature databases, data extraction, signal detection, causality assessment, integration with other data sources, and more.

DDReg’s services in medical and scientific literature monitoring constitute systematic tracking and the analysis of journals, clinical studies, and other relevant publications with the aim to identify emerging safety signals for pharmaceutical products. The team leverages their technical expertise in reviewing publications and access to indexed & non-indexed literature databases to provide crucial insight to enhance regulatory compliance and patient safety.

Literature monitoring is an indispensable pillar in pharmacovigilance as it offers a proactive lens into the dynamic landscape of pharmacovigilance. Its capacity to provide valuable insight from publications, capturing real-word drug experiences, and identifying emerging risks that would not be detected in clinical trials helps to truly encompass the safety profile of a drug. Indeed, in the dynamic realm of pharmacovigilance and post-market safety surveillance, literature monitoring is an essential tool in order to safeguard public health.

How can we help you?
Call us on:+1 (302) 601-2755
Contact our experts today !